Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Support Care Cancer. 2012 Aug 30;20(11):2999–3008. doi: 10.1007/s00520-012-1576-7

Table 2.

Serologic screening tests and clinical scenarios

Interpretation HBV
surface
antigen
(HBsAg)
Antibody
to HBV
core
antigen
(anti-HBc)
Antibody to
HBV
surface
antigen
(anti-HBs)
HBV
DNA
Chronic infection + + +
Carrier state + +
Convalescent from previous infection + +
Occult infection + +a
Prior vaccination +
a

If sensitive quantitative assays with limits of detection 5 IU/mL are used